Terns Pharmaceuticals Currently Down Seven Consecutive Days, on Track for Record Losing Streak -- Data Talk
Viking, Structure, Terns Benefitting From Disappointing Novo Nordisk Weight Loss Data
Applied Therapeutics, PowerFleet, VF Corp, Victoria's Secret And Other Big Stocks Moving Higher On Wednesday
Terns Pharmaceuticals(TERN.US) Director Buys US$5 Million in Common Stock
OrbiMed Advisors LLC Increases Stake in Terns Pharmaceuticals Inc
With 55% Ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Boasts of Strong Institutional Backing
BMO Capital Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Raises Target Price to $26
Express News | Terns Pharmaceuticals Inc : BMO Raises Target Price to $26 From $19
Analysts Offer Insights on Healthcare Companies: Amneal Pharmaceuticals (AMRX), Aura Biosciences Inc (AURA) and Terns Pharmaceuticals (TERN)
Terns Pharmaceuticals Prices $150.2 Million Public Offering
Terns Pharmaceuticals: Certain Investors Offered Pre-Funded Warrants to Purchase 2.4M Shares at $10.4999 Per Pre-Funded Warrant >TERN
Terns Pharmaceuticals: Gross Proceeds Expected to Be Approximately $150.15M >TERN
Express News | Terns Announces Pricing of Upsized $150.15 Million Public Offering
Mizuho Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $10
Terns Stock Soars on Positive Data From Phase I Study of Obesity Drug
Calavo Growers Posts Better-Than-Expected Earnings, Joins Tesla, Oracle, Mission Produce And Other Big Stocks Moving Higher On Tuesday
Oracle To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
Terns Pharma Analyst Ratings
JMP Securities Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Maintains Target Price $20
Jefferies Maintains Terns Pharmaceuticals(TERN.US) With Buy Rating, Raises Target Price to $30